KoBioLabs, Inc (KOSDAQ: 348150)

KoBioLabs Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	7,918	10,047	10,433	52,693	40,627	1,278
Short-Term Investments	49,643	56,194	82,514	33,989	10,348	31,641
Trading Asset Securities	-	-	-	2,003	-	-
Cash & Short-Term Investments	57,561	66,240	92,947	88,685	50,975	32,920
Cash Growth	-20.64%	-28.73%	4.81%	73.98%	54.84%	295.77%
Accounts Receivable	1,871	1,858	701.91	199.2	2,678	107.91
Other Receivables	1,247	3,020	4,279	3,118	2,475	979.86
Receivables	3,117	4,878	4,991	3,437	5,153	1,088
Inventory	4,105	1,467	977.47	256.21	105.56	122.96
Prepaid Expenses	1,306	1,765	1,852	2,133	1,442	505.82
Other Current Assets	2,398	1,378	1,711	4,108	134.87	18.8
Total Current Assets	68,487	75,729	102,478	98,619	57,810	34,655
Property, Plant & Equipment	31,786	34,858	20,485	5,791	383.21	384.51
Long-Term Investments	2,498	2,484	0	0	-0	-0
Other Intangible Assets	588.92	637.67	279.6	324.2	300.73	270.57
Other Long-Term Assets	1,033	914.62	687.14	541.7	43.32	11.29
Total Assets	104,393	114,623	123,930	105,285	58,537	35,322
Accounts Payable	1.68	-	-	-	-	68.59
Accrued Expenses	2,085	1,127	763.8	543.31	385.63	472.59
Short-Term Debt	3,781	8,633	1,700	-	-	-
Current Portion of Long-Term Debt	3,636	58.36	-	1,515	-	-
Current Portion of Leases	164.55	234.21	136.51	24.6	28.77	33.74
Current Unearned Revenue	746.37	775.09	120.24	632.53	270.89	64.82
Other Current Liabilities	4,503	10,323	6,223	4,124	2,404	80,609
Total Current Liabilities	14,918	21,151	8,944	6,840	3,089	81,248
Long-Term Debt	8,798	9,172	11,765	7,633	-	-
Long-Term Leases	121.89	195.96	180.53	24.37	57.1	72.99
Other Long-Term Liabilities	22,275	22,285	7,586	200	-	4.36
Total Liabilities	46,113	52,804	28,475	14,697	3,146	81,326
Common Stock	9,687	9,436	8,722	8,135	7,759	3,549
Additional Paid-In Capital	215,836	219,114	220,581	208,053	158,760	1,122
Retained Earnings	-166,775	-162,827	-148,975	-127,053	-111,671	-56,599
Comprehensive Income & Other	-17,877	-21,022	-3,736	577.08	543	-1,697
Total Common Equity	40,871	44,702	76,592	89,713	55,391	-53,624
Minority Interest	17,314	16,868	18,132	-	-	-
Shareholders' Equity	58,280	61,819	95,455	90,589	55,391	-46,004
Total Liabilities & Equity	104,393	114,623	123,930	105,285	58,537	35,322
Total Debt	16,503	18,294	13,782	9,197	85.87	106.73
Net Cash (Debt)	41,059	47,946	79,165	79,488	50,889	32,813
Net Cash Growth	-26.99%	-39.43%	-0.41%	56.20%	55.09%	294.49%
Net Cash Per Share	2154.42	2587.95	4713.30	4953.80	4747.27	4645.07
Filing Date Shares Outstanding	19.37	18.87	17.44	16.27	15.52	7.1
Total Common Shares Outstanding	19.37	18.87	17.44	16.27	15.52	7.1
Working Capital	53,569	54,578	93,535	91,779	54,721	-46,593
Book Value Per Share	2109.61	2368.65	4390.83	5513.80	3569.33	-7554.15
Tangible Book Value	40,282	44,064	76,312	89,388	55,090	-53,894
Tangible Book Value Per Share	2079.21	2334.86	4374.80	5493.88	3549.95	-7592.26
Land	6,477	6,477	6,477	-	-	-
Buildings	14,294	16,563	5,925	-	-	-
Machinery	10,872	4,569	3,920	859.78	634.9	500.98
Construction In Progress	-	8,766	4,929	5,321	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.